Toxic Reactions in Probable and Confirmed Methotrexate Overdose in Rheumatology Patients: A Case Series

Toxic Reactions in Probable and Confirmed Methotrexate Overdose in Rheumatology Patients: A Case Series

INTRODUCTION. Low-dose methotrexate (less than 30 mg/week) is the standard therapy for rheumatic diseases. Methotrexate overdose due to errors by patients or medical staff may lead to severe complications and life-threatening conditions.CASE DESCRIPTION. This article presents a retrospective analysi...

Full description

Saved in:

Bibliographic Details
Main Authors:	S. A. Doktorova, I. V. Andreeva, D. G. Krechikova, Yu. Yu. Grabovetskaya, O. S. Mazhaeva, V. V. Rafalskiy
Format:	Article
Language:	Russian
Published:	Ministry of Health of the Russian Federation, Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products» 2024-12-01
Series:	Безопасность и риск фармакотерапии
Subjects:	methotrexate toxicity overdose pancytopenia haemorrhages rheumatoid arthritis psoriatic arthritis medication errors drug safety clinical case
Online Access:	https://www.risksafety.ru/jour/article/view/454
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Mucocutaneous Adverse Effects of Methotrexate Toxicity: A Case Series
by: Bibek Subedi, et al.
Published: (2025-02-01)

Methotrexate in a psoriatic arthritis patient
by: K. V. Aleksanyan, et al.
Published: (2016-09-01)

Methotrexate in the treatment of rheumatoid arthritis and psoriatic arthritis
by: N. V. Chichasova, et al.
Published: (2021-06-01)

Efficacy and safety of rapid dose escalation of methotrexate in rheumatoid arthritis. Results of the multicenter “METEOR” study
by: V. N. Amirjanova, et al.
Published: (2025-03-01)

Methotrexate in the treatment of rheumatic disease
by: Marina Zinovyevna Kanevskaya, et al.
Published: (2013-12-01)

USE OF SUBCUTANEOUS METHOTREXATE FOR THE TREATMENT OF PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS: THE REMARCA TRIAL
by: D. E. Karateev, et al.
Published: (2016-07-01)

Insulin Predicts Methotrexate Response by Affecting the Transcription of Methotrexate Target Genes in the Treatment-Naive Rheumatoid Arthritis
by: Victoria M. E. Lundgren, et al.
Published: (2025-06-01)

Enhancing the Efficacy and Safety of Methotrexate Treatment: A Focus on Drug Interactions (Review)
by: S. A. Doktorova, et al.
Published: (2024-10-01)

NEW RECOMMENDATIONS FOR THE MANAGEMENT OF RHEUMATOID ARTHRITIS (EULAR, 2013): THE ROLE OF METHOTREXATE
by: Evgeniy L Nasonov, et al.
Published: (2014-03-01)

METHOTREXATE IN RHEUMATOID ARTHRITIS – 2015: NEW FACTS AND IDEAS
by: E. L. Nasonov
Published: (2015-09-01)

METHOTREXATE IN RHEUMATOID ARTHRITIS – 2015: NEW FACTS AND IDEAS
by: E. L. Nasonov
Published: (2016-12-01)

METHOTREXATE IN RHEUMATOID ARTHRITIS – 2015: NEW FACTS AND IDEAS
by: E. L. Nasonov
Published: (2015-10-01)

The importance of good adherence to methotrexate in the treatment of rheumatoid arthritis
by: Ćeranić Jelena, et al.
Published: (2025-01-01)

Adherence to Parenteral Methotrexate Compared to Oral Route in Patients with Rheumatoid Arthritis
by: Mariwan Ismail Othman, et al.
Published: (2025-03-01)

Prevalence of methotrexate intolerance among patients with rheumatoid arthritis in Erbil city using methotrexate intolerance severity score
by: Zhala Kakamin Mawlood, et al.
Published: (2024-03-01)

METHOTREXATE — «GOLD STANDARD» OF JUVENILE RHEUMATOID ARTHRITIS TREATMENT
by: Ye. I. Alekseyeva, et al.
Published: (2011-01-01)

Experience of therapy of psoriasis patients with methotrexate in the form of subcutaneous and intramuscularly injections
by: N. V. Zilberberg, et al.
Published: (2021-12-01)

Therapeutic drug monitoring of methotrexate and its metabolites in the red blood cells and mononuclear cells of patients with rheumatoid arthritis
by: G. I. Gridneva, et al.
Published: (2020-11-01)

The relationship between the efficacy of methotrexate in rheumatoid arthritis and the achieved level of its polyglutamates in erythrocytes (pilot study)
by: G. I. Gridneva, et al.
Published: (2019-05-01)

Hydroxychloroquine increases the exposure of methotrexate in plasma and red blood cells: a pharmacokinetic interaction study in rats in vivo
by: Guijie Zhang, et al.
Published: (2025-04-01)

Use of methotrexate in the treatment of psoriasis and psoriatic arthritis
by: Tatiana Viktorovna Korotaeva, et al.
Published: (2013-06-01)

What do we know about the possibility of predicting the potential efficacy and safety of methotrexate, by measuring the concentration of its metabolites in rheumatoid arthritis?
by: G. I. Gridneva, et al.
Published: (2020-09-01)

ISSUES OF OPTIMIZATION OF METHOTREXATE THERAPY IN PATIENTS WITH RHEUMATOID ARTHRITIS
by: G. I. Gridneva, et al.
Published: (2017-03-01)

Risks of Oral Methotrexate Administration in Outpatients
by: Maria Ganeva, et al.
Published: (2014-11-01)

Combined therapy with prospidin and methotrexate in rheumatoid arthritis (12 months controlled study)
by: B. F. Nemtsov, et al.
Published: (2003-06-01)

The reaction of the skin and its appendages in rheumatoid arthritis patients using subcutaneous methotrexate: A description of three cases
by: Yu. V. Muravyev, et al.
Published: (2016-10-01)

A 16-week multicenter observational study of the efficiency and safety of rheumatoid arthritis therapy with methotrexate
by: R. M. Balabanova
Published: (2018-12-01)

Influence of therapy with methotrexate, sulfasalazine and glucocorticoids on disease activity and erosions progression in patients with early rheumatoid arthritis
by: G Togizbaev, et al.
Published: (2007-10-01)

An erythrocyte macrocytosis by methotrexate is associated with early initiation of biologic or targeted synthetic agents in patients with rheumatoid arthritis
by: In-Woon Baek, et al.
Published: (2025-01-01)

WHY ARE THE RECOMMENDED METHOTREXATE DOSES NOT USED FOR THE TREATMENT OF RHEUMATOID ARTHRITIS: WHO IS GUILTY AND WHAT TO DO?
by: Yu. V. Muravyev, et al.
Published: (2017-03-01)

Retrospective analysis of cases with low dose methotrexate-induced neutropenia
by: Elif Dinçses Nas, et al.
Published: (2024-11-01)

TWELVE-WEEK MULTICENTER OPEN-LABEL RANDOMIZED COMPARATIVE STUDY OF THE EFFICACY AND SAFETY OF METHOTREXATE AS A CONCENTRATED SOLUTION FOR SUBCUTANEOUS ADMINISTRATION AND AS 15-MG TABLETS PER WEEK FOR RHEUMATOID ARTHRITIS
by: Yu. V. Muravyev, et al.
Published: (2016-07-01)

EFFICIENCY OF TRIPLE (METHOTREXATE + SULFASALAZINE + HYDROXYCHLOROQUINE) COMBINATION DISEASE-MODIFYING THERAPY VERSUS METOTREXATE MONOTHERAPY IN PATIENTS WITH RHEUMATOID ARTHRITIS
by: E E Gubar', et al.
Published: (2011-04-01)

Frequency and Causes of Methotrexate Intolerance and Discontinuation in Rheumatoid Arthritis Patients in Qena Governorate
by: Sondos Mohammed Sayed, et al.
Published: (2024-07-01)

The relationship between dose of methotrexate and incidence of liver fibrosis in patients with rheumatoid arthritis
by: Mina AkbariRad, et al.
Published: (2025-02-01)

Application of Microsponge Drug Platform to Enhance Methotrexate Administration in Rheumatoid Arthritis Therapy
by: Noemi Fiaschini, et al.
Published: (2024-12-01)

NEW POSSIBILITIES FOR MONITORING METHOTREXATE EFFICACY IN RHEUMATOID ARTHRITIS
by: Yu. V. Muravyev
Published: (2015-09-01)

Absence of metacarpophalangeal synovitis by high-resolution ultrasonography distinguishes psoriatic arthritis from rheumatoid arthritis – A cross-sectional study
by: Ashish K Badika, et al.
Published: (2021-01-01)

ANTI-INFLAMMATORY THERAPY FOR ATHEROSCLEROSIS: CONTRIBUTION TO AND LESSONS OF RHEUMATOLOGY
by: E. L. Nasonov, et al.
Published: (2017-10-01)

PENTOXIFILLIN INTHETREATMENTOF RHEUMATOID ARTHRITIS
by: I R Kolosova, et al.
Published: (2001-10-01)